top of page

An influx of COVID-19 related hospitalizations brings patients presenting a spectra of symptoms, requiring a spectra of treatments
– this convergence could lead to an increased risk of C. difficile.

If prioritized COVID-19 testing has you making tough decisions about your C. difficile testing standard and algorithm – it shouldn't!

  • Easy, flexible workflow – integrated seamlessly for a single specimen or high-throughput batching up to 12 tests at a time.

  • Minimal training – get up and running quickly

  • The Power of Virena – enhanced diagnostics featuring data analytics and surveillance

  • Compact footprint – measuring 9.4"x 9.4"x 5.9" deployable practically anywhere 

Anchor 1

Thank you for your message! A Quidel Inside Sales Representative will contact you shortly.

To learn how our Solana C. difficile Assay combined with the data-rich analytical tools of Virena can help you sustain your molecular testing algorithm, call

Quidel Inside Sales at 858.431.5814,

or fill out the form below:

Maintain your molecular testing standard for

C. difficile with Solana.

The Accurate. Sustainable.

Molecular C. difficile Solution.

bottom of page